Factores predictores, características patológicas y evolución de las recidivas vesicales después de nefroureterectomía
L. Mateu(Hospital Clínic de Barcelona), Antonio Alcaraz(Hospital Clínic de Barcelona), J. Huguet(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Mireía Musquera(Surgical Specialties (Canada)), Laura Izquierdo(Hospital Clínic de Barcelona), María J. Ribal(Hospital Clínic de Barcelona), E. Garcı́a-Cruz(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Albert Carrión(Universitat Autònoma de Barcelona)
Cited by 2
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
|European Urology|2020|313
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
|European Urology|2021|298